Chemed (CHE) VP granted 6,338 options at $443.79 on 10/21/2025

Q: What did CHE disclose on this Form 4?

An insider grant to Thomas C. Hutton of 6,338 stock options on 10/21/2025 at an exercise price of $443.79 per share.

Q: What is the exercise price and underlying security for CHE?

The options carry an exercise price of $443.79 and are tied to Chemed capital stock.

Q: When do the CHE options vest?

They vest in three equal annual installments, commencing on 10/21/2026.

Q: What is the expiration date of the CHE options?

The options expire on 10/21/2030.

Q: How many derivative securities does the insider hold after this transaction?

Following the transaction, Hutton beneficially owned 26,718 derivative securities.

Q: What is the insider’s relationship to Chemed (CHE)?

Hutton is a Director and Vice President of Chemed Corp.

Q: How is ownership reported for this CHE insider transaction?

The filing lists direct ownership of the derivative securities.

Chemed Corp (CHE) reported an insider equity award.

Accepted by SEC EDGAR 10/22/2025 - 04:12 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Chemed Corp (CHE) reported an insider equity award. Director and vice president Thomas C. Hutton filed a Form 4 showing a grant of 6,338 stock options on 10/21/2025, with an exercise price of $443.79 per share. The options relate to Chemed capital stock and expire on 10/21/2030.

The award vests in three equal annual installments commencing 10/21/2026. Following the reported transaction, Hutton beneficially owned 26,718 derivative securities. Ownership is reported as direct.

Insider Trade Summary

Grant/Award: 6,338 shares

Grant/Award 1 txn

Insider HUTTON THOMAS C

Role vice president

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy with tandem tax withholding)	6,338	$443.79	$2.81M

Holdings After Transaction: Stock Option (right to buy with tandem tax withholding) — 26,718 contracts (Direct)

Footnotes (1)

F1. Vesting in three equal annual installments commencing 10/21/2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CHE disclose on this Form 4?

An insider grant to Thomas C. Hutton of 6,338 stock options on 10/21/2025 at an exercise price of $443.79 per share.

What is the exercise price and underlying security for CHE?

The options carry an exercise price of $443.79 and are tied to Chemed capital stock.

When do the CHE options vest?

They vest in three equal annual installments, commencing on 10/21/2026.

What is the expiration date of the CHE options?

The options expire on 10/21/2030.

How many derivative securities does the insider hold after this transaction?

Following the transaction, Hutton beneficially owned 26,718 derivative securities.

What is the insider’s relationship to Chemed (CHE)?

Hutton is a Director and Vice President of Chemed Corp.

How is ownership reported for this CHE insider transaction?

The filing lists direct ownership of the derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUTTON THOMAS C

(Last)

(First)

(Middle)

1270 AVENUE OF THE AMERICAS

SUITE 1905

(Street)

NEW YORK

10020

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	vice president

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy with tandem tax withholding)	$443.79	10/21/2025		A		6,338		⁽¹⁾	10/21/2030	Capital Stock	6,338	$443.79	26,718	D

Explanation of Responses:

1. Vesting in three equal annual installments commencing 10/21/2026

	Thomas C. Hutton	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR